AlphaCentric Advisors’s Sanofi SNY Stock Holding History

AlphaCentric Advisors’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$693K	Buy	14,382 +788	+6%	+$36.7K	0.69%	37
2025 Q4	$659K	Buy	+13,594	New	+$674K	0.66%	43
2024 Q4	–	Sell	-17,500	Closed	-$1.01M	–	276
2024 Q3	$1.01M	Hold	17,500	–	–	0.75%	46
2024 Q2	$849K	Buy	17,500 +2,500	+17%	+$121K	0.63%	57
2024 Q1	$729K	Buy	+15,000	New	+$732K	0.44%	74
2023 Q2	–	Sell	-10,000	Closed	-$544K	–	272
2023 Q1	$544K	Sell	10,000 -10,000	-50%	-$486K	0.38%	82
2022 Q4	$969K	Sell	20,000 -35,500	-64%	-$1.56M	0.96%	37
2022 Q3	$2.11M	Buy	+55,500	New	+$2.47M	2.17%	4
2021 Q4	$301K	Buy	+6,000	New	+$297K	0.09%	82

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

AlphaCentric Advisors's SNY Position: Q1 2026 in Review

AlphaCentric Advisors increased its Sanofi (SNY) stake by 5.8% in Q1 2026, buying an estimated $36.7K and bringing the position to 14,382 shares worth $693K. The position accounts for 0.69% of the portfolio, ranked #37.

AlphaCentric Advisors first reported a position in SNY in Q4 2021 and has held it in 9 quarters since. The position peaked at $2.11M in Q3 2022. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

AlphaCentric Advisors held 14,382 shares of Sanofi worth $693K as of Q1 2026.
AlphaCentric Advisors bought 788 Sanofi shares in Q1 2026, an estimated $36.7K.
Sanofi made up 0.69% of AlphaCentric Advisors's portfolio in Q1 2026, its #37 holding.
AlphaCentric Advisors first reported a position in Sanofi in Q4 2021 and has held it in 9 quarters since.
AlphaCentric Advisors's Sanofi position peaked at $2.11M in Q3 2022.
737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on AlphaCentric Advisors's 13F filing for Q1 2026, filed 7 May 2026.